Pusztai Rozália
Szegedi Tudományegyetem, Altalános Orvostudományi Kar, Orvosi Mikrobiológiai és Immunbiológiai Intézet, Szeged.
Orv Hetil. 2009 May 24;150(21):963-8. doi: 10.1556/OH.2009.28614.
Primary and recurrent infections of human cytomegalovirus (HCMV) can occur during pregnancy. Both can result congenital infection, the leading infectious cause of mental retardation, sensorineural deafness and visual impairment. Intrauterine transmission of HCMV and adverse outcome are mainly related to primary maternal infection. However, there is an increasing evidence that incidence of symptomatic infections in infants born to immune mothers is higher than previously thought. Therefore the option of prenatal diagnosis has a crucial role in the management of pregnancy complicated by active HCMV infection. In spite of the potentially devastating consequence of congenital HCMV infection, little information is available concerning antiviral therapy as prophylactic treatment for women at high risk of the transmission of HCMV during pregnancy. Passive immunization for prevention of vertical transmission of the virus seems to be promising. Until a HCMV vaccine is available, education regarding the risk and strategies for prevention of HCMV infection during pregnancy is needed.
人巨细胞病毒(HCMV)的原发性和复发性感染可在孕期发生。两者均可导致先天性感染,这是智力迟钝、感音神经性耳聋和视力损害的主要感染原因。HCMV的宫内传播及不良后果主要与母亲原发性感染有关。然而,越来越多的证据表明,免疫母亲所生婴儿中症状性感染的发生率高于此前的认知。因此,产前诊断对于处理合并活动性HCMV感染的妊娠至关重要。尽管先天性HCMV感染可能带来毁灭性后果,但关于抗病毒治疗作为孕期HCMV传播高危女性预防性治疗的信息却很少。被动免疫预防病毒垂直传播似乎很有前景。在有HCMV疫苗可用之前,需要开展关于孕期HCMV感染风险及预防策略的教育。